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Transient receptor potential (TRP) proteins are a family of ion channels, which are respon-
sible  for a wide array of cellular functions. In particular, TRP melastatin type (TRPM) 7 is
expressed everywhere and permeable to divalent cations such as Mg2+ and Ca2+. It contains
a  channel and a kinase domain. Recent studies indicate that activation of TRPM7 plays an
important role in the growth and survival of gastric cancer cells. In this review, we describe
and  discuss the ﬁndings of recent studies that have provided novel insights of the relation
between TRPM7 and gastric cancer.
©  2016 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND licenseion channel
proliferation
transient receptor potential
melastatin 7
TRPM7
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
in tumorigenesis and tumor progression. Accordingly, Ca1.  Introduction
Gastric cancer is responsible for almost 1 million deaths
worldwide per year, and thus is an important global health-
care issue. Although the age-adjusted mortality of gastric
cancer has decreased over the past few decades, it remains
the third leading cause of cancer-related mortality.1 Cyto-
solic free Ca2+ concentration ([Ca2+]i) changes represent a
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2213-4220/© 2016 Korea Institute of Oriental Medicine. Published by Else
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ubiquitous signaling mechanism, which integrates with other
signal-transduction cascades and controls a variety of cellular
processes.2 Alterations of calcium signaling and homeosta-
sis have wide ranging consequences, and it is not surprising
that some Ca2+-mediated signaling pathways are implicated
3–5 2+Longevity and Biofunctional Medicine, Pusan National University
channels are crucial for a wide variety of biological processes,
including tumor development and cancer growth.6,7 Transient
receptor potential (TRP) proteins are a family of ion channels
vier. This is an open access article under the CC BY-NC-ND license
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nd are responsible for many  cellular functions. They were
nitially identiﬁed in Drosophila,  in which spontaneously occur-
ing mutations in the trp and trpl genes selectively abolish the
elayed, light-sensitive, sustained depolarization caused by
a+ and Ca2+ inﬂux into photoreceptors.8 As a consequence,
RP Drosophila mutants exhibit transient rather than sus-
ained light sensitive depolarization and receptor potentials,
hich are used to designate TRP channels.9 These channels
ave been shown to be gated by a variety of physical and
hemical stimuli, such as stretch, temperature changes, and
 large number of endogenous (e.g., diacylglycerol and Ca2+)
nd exogenous ligands. Furthermore, some of these channels
ave been reported to be activated by intracellular Ca2+-store
epletion.8–10
Research over the years has added considerably to our
nowledge of the expressions and functional aspects of
RP melastatin 7 (TRPM7) channels. TRPM7 currents have
n outward-rectifying cation current with reversal poten-
ial of 0 mV. However, in the absence of external divalent
ations, TRPM7 outward rectiﬁcation is largely abolished.11
lso, TRPM7 has a property of more  permeability with trace
etal ions. Monteilh-Zoller et al11 published a permeation
roﬁle order for TRPM7, as follows: Zn2+ ≈ Ni2+  Ba2+ > Co2+
 Mg2+.
TRPM7 currents are evoked with pipette solutions lacking
agnesium or magnesium adenosine triphosphate and acti-
ated constitutively in whole-cell conﬁguration patch clamp
xperiments.12 TRPM7 has the same properties as TRPM6.
irst, they Exhibit 49% primary amino acid sequence identity.
n addition, they are Mg2+ and Ca2+ permeable ion chan-
els with a channel kinase (atypical -kinases) and show
g2+ and Ca2+ permeable ion channels.13–15 Recent studies
ave demonstrated that the TRPM7 channels can be mod-
lated by 2-aminoethoxydiphenyl borate (2-APB). 2-APB can
e used to differentiate between TRPM7 and TRPM6. 2-APB
nhibits TRPM7 currents but potentiates TRPM6 at micromo-
ar concentrations.15,16 TRPM7 is also inhibited by carvacrol,17
-lipoxygenase (LOX) inhibitors (NDGA, AA861, and MK886),18
afamostat mesylate,19 Ca2+-activated small conductance K+
hannel blocker NS8593,20 waixenicin A,21 sphingosine, and
TY720.22 TRPM7 channel activity is regulated by extracellular
H,23 and although the effects of protons on TRPM7 currents
emain controversial,24–26 it is known that TRPM7 can be reg-
lated by acidic conditions, which is associated with ischemic
troke.27,28
TRPM7 channel is ubiquitously expressed in almost all
issues,29,30 and several research groups31–34 have suggested
hat it is closely associated with cellular growth and devel-
pment under physiological conditions. Furthermore, the
verexpression of TRPM7 in HEK-293 cells has been reported
o lead to cell rounding and reduced adhesion and m-calpain
ctivation,35,36 which suggest that TRPM7 also plays a role
n cell adhesion. In sympathetic neurons, synaptic vesicles
ave TRPM7 proteins, and in synaptic vesicles, synaptic vesic-
lar synapsin 1, synaptotagmin 1, and snapin form complexes
ith TRPM7.37 In addition, TRPM7 channel has a characteris-
37ic to alter acetylcholine release in neurons. TRPM7 also has
n important role in cardiac pathophysiology. TRPM7 is criti-
al for myocardial proliferation during early cardiogenesis,38
nd impaired automaticity in Trpm7-deleted sinoatrial node125
cells induces abnormal diastolic depolarization, associated
with a slowed diastolic Ca2+ rise and reduced pacemaker cur-
rent If (encoded by Hcn4 expression).39 In the gastrointestinal
tract, TRPM7 protein is essentially required for the pacemak-
ing activities of interstitial cells of Cajal.28,40
Recently, many  research studies have been conducted
about the relationship between TRPM7 channel and cancer,
such as the regulation of tumor proliferation, differentiation,
apoptosis, angiogenesis, migration, and invasion.30,31 More-
over, TRPM7 overexpression has been found in head and neck
carcinoma,41 retinoblastoma,33 breast cancer,42 and in gas-
tric cancer.43 Thus, TRPM7 channel is an important diagnostic
and/or prognostic marker, and is a recognized target for phar-
maceutical intervention. Nevertheless, further investigations
are required to improve our understanding of the role of
TRPM7 channel in cancer.28,41 In this review, we  discuss the
ﬁndings of recent studies and provide novel insights of rela-
tions between TRPM7 and gastric cancer.
2.  Gastric  cancer
Gastric cancer is responsible for considerable morbidity and
mortality, and is the third leading cause of cancer-related
death in men  and women.1 Clinically, the symptoms of gastric
cancer tend to emerge late during disease development, and
thus treatment options are often limited. However, the search
to ﬁnd an optimal treatment continues amid improvements in
our understanding of key aspects of its pathogenesis, which
undoubtedly improve the likelihood of our identifying poten-
tial therapeutic targets. The majority of gastric cancers are
adenocarcinomas, and traditionally gastric cancer is classiﬁed
as intestinal or diffuse, as described by Lauren.44 In general,
gastric cancer arises from a gastric change, such as atrophic
gastritis, which then develops into intestinal metaplasia and
dysplasia. Moreover, Helicobacter pylori infection often induced
gastric cancer through a chronic inﬂammation.45 By contrast,
diffuse gastric cancer is associated with pathological charac-
teristics, such as loss of cell cohesion and signet ring cells,
and (usually) negative H. pylori conditions.45 In the past several
years, many  advances in science and technology have pro-
vided greater opportunity for molecular treatments of gastric
cancer.46
3.  TRPM7  channels  and  gastric  cancer
The TRPM7 cation channel supports multiple cellular and
physiological functions, including cell death. Jiang et al25 sug-
gested that TRPM7 channel inhibits the growth and prolifera-
tion of FaDu and SCC25 cells, two common human head and
neck squamous carcinoma cell lines. Furthermore, suppres-
sion of TRPM7 channels by Gd3+, 2-APB, or small interfering
RNA (siRNA) about TRPM7 inhibited the growth and prolifera-
tion of these cells.25 TRPM7 is required for pancreatic adeno-
carcinoma cell proliferation and metastasis via the mitogen-
activated protein kinase (MAPK) pathway.47,48 In the BxPC-3
cell line, dialyzing cytoplasm during patch clamp whole-cell
recordings with a Mg2+ free pipette solution activated a non-
selective cation current with strong outward rectiﬁcation,
126  
and this cation current was inhibited by intracellular Mg2+
depletion and by TRPM7 silencing.47 In another study,
TRPM7-deﬁcient cells underwent replicative senescence after
exhibiting p16 (CDKN2A) and WRN  mRNA  upregulation, and
in the same study anti-TRPM7 siRNA and gemcitabine in com-
bination were found to be more  toxic to cells than gemcitabine
alone.48 TRPM7 levels in human breast cancer indicate that its
overexpression may be a characteristic of higher-grade, highly
proliferative breast cancer,49 which is in line with its calcium-
independent kinase activity (MAPK pathway activation and
regulation of cellular adhesion).50,51 In addition, it has been
proposed TRPM7 may play a role in the proliferation of MCF-
7 breast cancer cells. TRPM7 was also found to facilitate 5-8F
cell migration by enabling Ca2+ inﬂux, and thus it was sug-
gested as a potential therapeutic target for nasopharyngeal
carcinoma.52 TRPM7 also plays an important role in the epi-
dermal growth factor (EGF)-induced migration of A549 cells
and thus is also viewed as a potential therapeutic target in
lung cancer53; in fact, TRPM7 is expressed in lung carcinoma
tissues. TRPM7 is regulated at the mRNA  and protein levels by
EGF, which activated cell migration in this lung cancer model.
In another study, the role of TRPM7 in migration was evalu-
ated by siRNA knockdown and by nonspeciﬁc pharmacological
inhibition, and its inhibition was found to reduce cell migra-
tion under basal or EGF-activated conditions.53 Sun et al54 pro-
posed that the cholesterol-induced activation of TRPM7 regu-
lates human prostate cell proliferation, migration, and viabil-
ity. Cholesterol increases Ca2+ entry via the TRPM7 channel,
which promotes the proliferation of prostate cells by inducing
the activations of the AKT and/or ERK pathways.54 TRPM7 also
regulates the mobility of PCa cells via cholesterol-dependent
calcium entry, and high levels of circulating cholesterol have
been shown to increase the risk aggressiveness of these cells.55
Cholesterol activates TRPM7 channel, which in turn increases
basal intracellular calcium concentrations and stimulates cal-
pain (a calcium dependent protein), which in turn decreases
E-cadherin expression, and suggests a possible link between
TRPM7 and migration.54 Mizuno et al56 reported that TRPM7-
overexpressing MBT-2  cells proliferated more  slowly than
mock-transfected cells, and suggested that TRPM7 serves as a
negative regulator of bladder cancer cell proliferation.56 Wang
et al57 concluded that TRPM7 is required for ovarian cancer
cell growth, migration, and invasion, and their mechanis-
tic investigation revealed that silencing of TRPM7 decreased
the phosphorylations of Akt, Src, and p38 and increased ﬁl-
amentous actin levels in ovarian cancer cells and their focal
adhesion.57 TRPM7 is also involved in tumor progression; for
example, it has been reported to contribute to neuroblastoma
progression by maintaining progenitor-like features through
a developmental transcriptional program involving the tran-
scription factor SNAI2.58 Accordingly, it appears TRPM7 plays
an important role in the regulation of cancer cell death.
Recently, we  investigated the presence and potential roles
of TRPM7 channels during the growth and survival of gastric
cancer cells using mainly electrophysiological and molecular
techniques. Reverse transcription polymerase chain reaction
detected the presence of TRPM7 mRNA  in human gastric
adenocarcinoma cell lines (AGS, MKN-1, MKN-45, SNU-1,
and SNU-484), and the expressions of TRPM7 proteins in
these lines were further conﬁrmed by Western blotting andIntegr Med Res ( 2 0 1 6 ) 124–130
immunostaining.43 In this study, we mainly used the AGS
cell line, a commonly used human gastric adenocarcinoma
cell line. Whole-cell voltage clamp recordings were used to
investigate electrophysiological characteristics in AGS cells,
and a voltage ramp from +100 mV to –100 mV was found to
evoke small inward currents at negative potentials, whereas
larger outward currents were evoked at positive potentials,
which is indicative of outward-rectifying cation currents. In
a divalent-free solution, however, large inward and outward
currents were shown with little rectiﬁcation. Furthermore,
the amplitudes of TRPM7-like currents were larger at low
Mg2+ concentrations, and the presence of 2 mM Mg2+ inter-
nally signiﬁcantly inhibited these currents. In addition, the
median inhibitory concentration value for free Mg2+ was found
to be 560 M in AGS cells.43 These features are similar to
those of recently cloned TRPM6 and TRPM7 channels.59,60
To differentiate TRPM6 and TRPM7, we used 2-APB.11 2-APB
(at micromolar concentrations) enhanced TRPM6 currents
but inhibited TRPM7 currents,11 demonstrating the involve-
ment of TRPM7 channels and not of TRPM6 channels. To
conﬁrm that this TRPM7-like current was really mediated
by TRPM7 channel activation, we  transfected approximately
90% of AGS cells with siRNA. TRPM7 siRNA knocked down
TRPM7 protein expression by 70–80% without reducing the
expression of the internal control. To conﬁrm if TRPM7
siRNA had reduced TRPM7 protein expression, cells were ana-
lyzed by electrophysiology, and it was subsequently found
that the amplitudes of TRPM7-like currents were signiﬁ-
cantly reduced in TRPM7 siRNA transfected AGS cells. We
then sought to determine whether the activities of TRPM7
channels inﬂuence cell survival, and the subsequent MTT  [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide]
assay showed signiﬁcant apoptosis among AGS cells trans-
fected with TRPM7siRNA. In addition, we  found that Mg2+ was
critical for the growth and survival of AGS cells.43
More recently, in a study on ginseng (the root of Panax gin-
seng C.A. Meyer and a well-known folk medicine and tonic),
ginseng total saponin (GTS)61 and ginsenosides Rg362 and
Rd63 were found to induce AGS cell death by blockading
TRPM7 channel activity. Thus, these results suggested that
TRPM7 channels are involved in GTS, ginsenoside Rg3, and Rd-
induced gastric cancer cell apoptosis. Furthermore, zinc ions,
like calcium, have been reported to play an vital role in cellular
homeostasis in various physiological conditions.64,65 Zinc has
a function of a range of enzymes associated with transcription,
translation, protein synthesis, and signal transductions.66 In
fact, TRPM7 is the only known zinc-permeable channel in
the TRP channels,8,11,67 and the zinc permeability of TRPM7
is fourfold higher than its Ca2+ permeability.11 We  found
that the activation of TRPM7 channel augmented the Zn2+-
induced AGS cell apoptosis, and that the TRPM7 overexpressed
HEK293 cells increased Zn2+-induced cell damage.62 There-
fore, it appears that TRPM7 channel also represents a new
target for physiological diseases in which Zn2+ toxicity plays
an important role.
Regarding the effects of various TRPM7 blockers on gastric
cancer cells, Chen et al18 suggested that the LOX inhibitors,
nordihydroguaiaretic acid (NDGA), 3-[1-(p-chlorobenzyl)-5-
(isopropyl)-3-tert-butylthioindol-2-yl]-2,2-dimethylpropanoic
acid (MK886), and 2,3,5-trimethyl-6-(12-hydroxy-5,
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Fig. 1 – Summary of the roles of TRPM7 channel during the proliferation, migration, invasion, and metastasis of various
cancers.
Q
T
1
T
f
i
a
a
A
l
s
T
u
a
s
i
t
w
c
i
v
m
a
e
v
m
g
M
i
q
i
c
c
i
auestion mark (?) means little researched until now.
RPM7, transient receptor potential melastatin 7.
0-dodecadiynyl)-1,4-benzoquinone (AA861) potently block
RPM7 channel, and are capable of attenuating TRPM7
unction, but found that zileuton (another 5-LOX speciﬁc
nhibitor) was ineffective at suppressing TRPM7 channel
ctivity. Zierler et al21 suggested that waixenicin A is also
 potent inhibitor of TRPM7. In gastric cancer cells, NDGA,
A861, MK886, and waixenicin A all potently blocked TRPM7-
ike currents and induced cell death, but zileuton did not
uppress TRPM7-like current activity or induce cell death.68,69
o conﬁrm the effects of TRPM7 channel blockers, we also
sed a pyrazole compound (Pyr3; a speciﬁc TRPC3 inhibitor)70
nd 9-phenanthrol (a speciﬁc TRPM4 inhibitor).71 These
peciﬁc inhibitors did not affect TRPM7-like currents or
nduce gastric cell death. Therefore, our ﬁndings suggested
hat the TRPM7-speciﬁc blockers, NDGA, MK886, AA861, and
aixenicin A play an important role in the survival of gastric
ancer cells.68,69 Quercetin (3,3′,4′,5,7-pentahydroxyﬂavone)
s one of the most distributed ﬂavonols found in many  fruits,
egetables, leaves, and grains.72 Furthermore, quercetin has
any (patho)physiological properties, such as anticancer,
nti-inﬂammatory, antiatherogenic, and antihypertensive
ffects.72 Thus, we  investigated the effects of quercetin in
arious gastric adenocarcinoma cell lines and explored the
echanisms responsible for its activities. Quercetin induced
astric cancer cell apoptosis, and this was inhibited by various
APK inhibitors, such as p38 kinase inhibitor (SB203580), JNK
nhibitor (SP600125), and ERK inhibitor (PD98059). In addition,
uercetin inhibited TRPM7 currents. Moreover, quercetin-
nduced cell death was increased with upregulation of TRPM7
hannels. These results suggest that quercetin induces gastric
ancer cell apoptosis through both MAPK and TRPM7 channel
nhibition.73 Accordingly, we  suggest that quercetin might be
 therapeutic drug for the treatment of gastric cancer.Traditional medicine is mainly based on the use of plants,
and some of the many  herbal medicines may be useful
for the treatment of cancer.74,75 These medicines usually
contain many  compounds that affect multiple targets,76,77
and these combinations of multiple drugs are considered
to maximize therapeutic efﬁcacy by facilitating synergis-
tic effects and preventing potential adverse effects, which
complicates efforts to identify the mechanisms involved.
Orostachys japonicus (OJ) is used in traditional medicine and
has anti-inﬂammatory, antifebrile, hemostatic, antidote, and
anticancer activities.78,79 During our studies, we  found that
OJ extract inhibited the growth and survival of gastric cancer
cells by blockading TRPM7 channel activity.80 Also, Sophorae
Radix extract and Ulmi Pumilae Cortex extract showed the same
mechanism in inhibition of gastric cancer cell survival with
OJ extract.81,82 However, Buxus microphylla var. Koreana Nakai
extract (BMKNE) inhibited the survival of gastric cancer cells
through both the blockade of the TRPM7 channel’s activity and
MAPK signaling.83 Therefore, we suggested that these extracts
regulate the survival of gastric cancer cells through TRPM7
channels. However, the roles of TRPM7 in migration, inva-
sion, and metastasis in gastric cancer have yet to be addressed
(Fig. 1).
4.  Conclusion
Gastric cancer remains a major health problem because of
its incidence, poor prognosis, and limited treatment options.
Although the age-adjusted mortality of gastric cancer has
decreased over the past few decades, more  studies are
required to understand the mechanisms underlying known
antigastric cancer effects. Ion channels play important roles
r128  
in a variety of biological processes and diseases, and of these,
a number of Ca2+ channels have been linked with cancer
cell behaviors and with the pathophysiological hallmarks
of cancer. Changes in activation and/or in the expressions
of Ca2+-transporting proteins not only change global Ca2+
homeostasis, but also may cause modiﬁcations in subcel-
lular Ca2+ microdomains and localized Ca2+signals, which
can affect Ca2+-dependent signaling processes relevant to
tumorigenesis. Most of these Ca2+ channels are not speciﬁc to
cancer cells and are expressed in numerous normal tissues,
but some are more  active or are overexpressed in cancer cells.
Furthermore, the expressions of a variety of TRP channels are
different in the same cancer types. Based on available reports,
it is likely that several types of channels can contribute to
and cooperate during single tumorigenic processes, or can
be involved at different stages of sequences of events asso-
ciated with tumorigenesis. However, as these reports do not
support the idea that single channels are related to speciﬁc
cancer types, it remains to be determined whether any such
speciﬁc associations exist.5 In particular, although it has been
established that activation of TRPM7 channel plays important
roles in the growth and survival of gastric cancer cells, little
is known of its molecular role during the initiation and/or
progression of gastric cancer or of the involvement of calcium
signaling through TRPM7 channels on the regulation of prolif-
eration and apoptosis. In addition, there are no experiments
on human gastric cancer patients or specimens. Research
has only provided basic evidence for the involvement of
TRPM7 channels in gastric cancer. In the future, widespread
pharmacological interest on the link between TRPM7 and
gastric cancer will create opportunities for researchers to test
these mechanisms clinically in gastric patients over the next
few years. The speciﬁc antagonists for TRPM7 channels have
also been described in the basic and preclinical area, and are
progressing into clinical evaluation. With these speciﬁc antag-
onists for TRPM7 channels, TRPM7 channels will provide the
therapeutic mechanisms for the treatment of gastric cancer
patients. In our opinion, studies on the anticancer effects of
ion channels are likely to result in the development of novel
anticancer therapy protocols with improved outcomes.
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